Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWishbone Regulatory News (WSBN)

Share Price Information for Wishbone (WSBN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.275
Bid: 1.25
Ask: 1.30
Change: 0.025 (2.00%)
Spread: 0.05 (4.00%)
Open: 1.25
High: 1.275
Low: 1.25
Prev. Close: 1.25
WSBN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed termination of equity sharing facility

17 Oct 2018 16:04

RNS Number : 3895E
Wishbone Gold PLC
17 October 2018
 

17 October 2018

 Wishbone Gold Plc

("Wishbone" or the "Company")

Wishbone Gold Plc / Index: AIM: WSBN / Sector: Natural Resources / NEX: WSBN 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR").

Proposed termination of equity sharing facility and related arrangements and proposed fundraising

Termination of the equity sharing arrangements

The Company announces that it has entered into an agreement (the "Agreement") with D-Beta One EQ, Ltd. ("D-Beta") pursuant to which, inter alia, the parties have agreed to suspend the monthly payments due to be made for May, June, July, August, September, October and/or November (as appropriate) 2018 (the "Deferred Monthly Payments") in respect of the equity sharing facility (the "Equity Sharing Facility") entered into by the Company with D-Beta, which was announced by the Company on 18 August 2017. The net amount payable in respect of the Deferred Monthly Payments is currently anticipated to be £119,683.84 payable by the Company to D-Beta. The Agreement also provides, inter alia, that:

- purchasers will be sought for 88,235,714 existing ordinary shares of 0.1 pence each in the capital of the Company currently held by D-Beta (the "Sale Shares");

- subscribers will be sought for new ordinary shares of 0.1 p each (the "New Ordinary Shares") in the capital of the Company (the "Placing Shares") to raise gross proceeds of approximately £550,000;

- the sale of the Sale Shares is to be conditional, inter alia, on admission to trading on AIM of the Placing Shares;

- neither the sale of the Sale Shares nor the placing of the Placing Shares will be underwritten;

- subject to receipt by D-Beta of the net proceeds of the sale of the Sale Shares and receipt by the Company of the net proceeds of the issue of the Placing Shares, in each case by 28 November 2018, the final amount to be paid by or to the Company as the case may be (the "Final Payment Amount") in order to terminate the Equity Sharing Facility will be agreed by the parties or determined by the Company's auditors and such amount will relate not only to the Deferred Monthly Payments but also to each further anticipated monthly payment to be made under the Equity Sharing Facility (each such further anticipated monthly payment being defined as a "Further Payment"). It is currently anticipated that the Final Payment Amount will be approximately £119,683.84 payable by the Company to D-Beta but the actual amount of the Final Payment Amount will depend on, inter alia, the price at which the Sale Shares are sold and the Placing Shares are subscribed for;

 - in the event that the net proceeds of the Share Sale and the Placing are not received by D-Beta and the Company respectively by 28 November 2018 then the payment of the Monthly Deferred Payments will be deferred to December 2018 and January, February, March and April 2019 respectively and the payment of each Further Payment will be deferred by 7 months respectively; and

-the Investment Agreement entered into between the Company and YA II PN, which was announced by the Company on 18 August 2017 (pursuant to which the Company was loaned US$400,000 for a 12-month term at an initial interest rate of 10% per annum) be terminated and the 8,934,663 warrants granted by the Company pursuant to the terms terms of the Investment Agreement be cancelled. The Company will make a payment of approximately £273,900.69 in full and final settlement of the Investment Agreement.

Proposed fundraising

The Company announces that it is proposing to raise a total of approximately £550,000 (before expenses) through the issue of 550,249,726 Placing Shares at a placing price of 0.10 pence (the "Placing Price") per Placing Share (the "Placing"). In addition, D-Beta proposes to arrange the sale of 88,235,714 Sale Shares at the Placing Price. It is proposed that for each 2 Placing Shares subscribed in the Placing investors will receive a warrant to subscribe 1 New Ordinary Share in the capital of the Company exercisable at the Placing Price for a period of 2 years from admission of the Placing Shares to trading on AIM. Likewise, it is proposed that for each 2 Sale Shares to be sold, investors will receive a warrant to subscribe 1 New Ordinary Share exercisable at the Placing Price for a period of 2 years from admission of the Placing Shares to trading on AIM.

 It is proposed that the net proceeds of the Placing will be used for working capital and to settle amounts due to D-Beta under the Equity Sharing Facility and/or the Investment Agreement as referred to above.

Capitalisation of Directors' Fees

Following the placing it is intended that liabilities in the region of £250,000 representing amounts of fees and expenses owed to directors up to September 2018 will be capitalised into Ordinary Shares. These Ordinary Shares will be allotted at the higher of the closing mid-market price on the day of completion of the placing or the par value of the Ordinary Shares (the "Capitalisation Shares"). Warrants will not be granted to the holders of the Capitalisation Shares. A further announcement will be made tomorrow regarding the allotment of the Capitalisation Shares and an application is expected to be made for the Capitalisation Shares to be admitted to trading on AIM, with dealings are expected to commence on 31 October 2018.

Further announcements will be made in due course.

For more information on Wishbone please visit the Company's website www.wishbonegold.com

 

 

 Enquiries:

 Wishbone Gold PLC

Richard Poulden, Chairman Tel: +44 207 812 0645

 Allenby Capital Limited

(Broker, Corporate Adviser and Nominated Adviser)

Nick Naylor/Nick Harriss Tel: +44 203 328 5656

 Damson Communications

(Public Relations)

Abigail Stuart-Menteth/Amelia Hubert Tel: +44 20 7812 0645

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFESIDLDLIT
Date   Source Headline
30th Sep 20201:28 pmRNSAnnual Financial Report
24th Sep 20207:29 amRNSUpdate on the Exercise of Conversion Warrants, TVR
7th Sep 20207:00 amRNSDrilling approved for Wishbone’s Australian Assets
1st Sep 20202:03 pmRNSUpdate on the Application for Block Listing
26th Aug 20204:41 pmRNSSecond Price Monitoring Extn
26th Aug 20204:35 pmRNSPrice Monitoring Extension
26th Aug 202011:16 amRNSIssue of Equity and Application for Block Listing
20th Aug 20207:00 amRNSFunding Raised to Expand Exploration Program
19th Aug 20207:05 amRNSGold Exploration to Commence on Australian Targets
30th Jun 20203:04 pmRNSTrading Update and Extension of Reporting Deadline
17th Jun 202010:24 amRNSHolding in the Company
2nd Jun 20207:00 amRNSIssue of Equity, Appointment of Broker and TVR
2nd Apr 20203:14 pmRNSResult of AGM
12th Mar 20204:33 pmRNSNotice of AGM
17th Feb 20207:00 amRNSAcquisition of Deferred Shares
21st Jan 20207:00 amRNSCapital Reorganisation
10th Jan 20203:56 pmRNSResult of EGM and Capital Reorganisation Update
7th Jan 202011:51 amRNSIssue of Shares
19th Dec 20191:06 pmRNSTrading Update and Notice of GM
30th Sep 20197:00 amRNSInterim Results
2nd Jul 201912:39 pmRNSResults of EGM
28th Jun 20197:00 amRNSFinal Results
11th Jun 20193:01 pmRNSNotice of EGM
4th Jun 20197:00 amRNSNEX Suspension
28th May 20194:17 pmRNSHolding in the Company
22nd May 201911:06 amRNSSecond Price Monitoring Extn
22nd May 201911:00 amRNSPrice Monitoring Extension
21st May 20194:41 pmRNSSecond Price Monitoring Extn
21st May 20194:35 pmRNSPrice Monitoring Extension
21st May 20192:31 pmRNSGeneral Trading Update
3rd Apr 201911:52 amRNSTotal Voting Rights
8th Mar 20194:41 pmRNSSecond Price Monitoring Extn
8th Mar 20194:36 pmRNSPrice Monitoring Extension
28th Feb 20194:30 pmRNSTotal Voting Rights
26th Feb 20192:42 pmRNSExercise of Warrants
7th Feb 20192:00 pmRNSChange of Nominated Adviser
29th Jan 20193:05 pmRNSExercise of Warrants
22nd Jan 20192:12 pmRNSCorrections of shares in admission
18th Jan 20199:00 amRNSPrice Monitoring Extension
11th Jan 20197:00 amRNSExercise of Warrants
3rd Jan 201911:08 amRNSResult of AGM
31st Dec 201811:40 amRNSExercise of warrants
31st Dec 20187:00 amRNSConversion of Sanderson Loan
21st Dec 20187:00 amRNSPlacing of New Ordinary Shares
19th Dec 20181:26 pmRNSWishbone and Partners Receive Honduras License
4th Dec 20187:00 amRNSNotice of Annual General Meeting of Shareholders
30th Nov 20187:00 amRNSTotal Voting Rights
19th Nov 20187:00 amRNSAlign Research Note
31st Oct 20181:38 pmRNSIssue of New Ordinary Shares & Total Voting Rights
22nd Oct 20182:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.